Your browser doesn't support javascript.
loading
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
Ribolsi, Mentore; Frazzoni, Marzio; Marabotto, Elisa; De Carlo, Giovanni; Ziola, Sebastiano; Maniero, Daria; Balestrieri, Paola; Cicala, Michele; Savarino, Edoardo.
Afiliação
  • Ribolsi M; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
  • Frazzoni M; Digestive Pathophysiology Unit, Baggiovara Hospital, Modena, Italy.
  • Marabotto E; Ospedale Policlinico San Martino, Genova, Italy.
  • De Carlo G; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
  • Ziola S; Ospedale Policlinico San Martino, Genova, Italy.
  • Maniero D; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.
  • Balestrieri P; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
  • Cicala M; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
  • Savarino E; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.
Aliment Pharmacol Ther ; 54(4): 412-418, 2021 08.
Article em En | MEDLINE | ID: mdl-34181753
ABSTRACT

BACKGROUND:

The Lyon Consensus delineates impedance-pH parameters that can demonstrate/exclude gastro-oesophageal reflux disease (GERD). In patients with acid exposure time between 4% and 6%, GERD diagnosis has been considered inconclusive. In these cases, mean nocturnal baseline impedance (MNBI) and post-reflux swallow-induced peristaltic wave (PSPW) index may either confirm or refute GERD diagnosis and represent predictors of proton pump inhibitor (PPI) response.

AIMS:

To investigate the diagnostic yield of MNBI and PSPW index and their relationship with PPI response in patients with inconclusive GERD diagnosis.

METHODS:

Review of impedance-pH tracings from PPI responder/non-responder patients with typical reflux symptoms. Multivariate regression analysis was performed to determine the association of MNBI and PSPW index to PPI response.

RESULTS:

Among 233 patients evaluated, 145/233 (62.2%) were PPI responders; 62 had conclusive and 65 inconclusive evidence of GERD, 46 had reflux hypersensitivity, and 60 functional heartburn. Abnormal MNBI and PSPW index were significantly more frequent in inconclusive GERD as compared to the functional heartburn group (P < 0.001). Within the inconclusive GERD group, 35/65 (54%) patients were PPI responders and displayed a significantly higher proportion of cases with pathological MNBI or PSPW index as compared to non-responders (32/35 [91.4%] and 30/35 [85.7%] vs 9/30 [30%] and 7/30 [23.3%], P < 0.001). By multivariate analysis, pathological PSPW index and/or MNBI values were significantly associated with PPI response in all groups.

CONCLUSIONS:

The present study highlights the value of MNBI and PSPW index as adjunctive metrics in characterising patients with inconclusive evidence of GERD and identifying those responsive to PPI treatment.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Refluxo Gastroesofágico / Inibidores da Bomba de Prótons Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Refluxo Gastroesofágico / Inibidores da Bomba de Prótons Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article